External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study.
Eur Urol Focus
; 2(3): 303-309, 2016 Aug.
Article
in En
| MEDLINE
| ID: mdl-28723377
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Eur Urol Focus
Year:
2016
Document type:
Article
Country of publication:
Netherlands